Status:
COMPLETED
Cannabinoid Receptor Function & Alcoholism
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Alcoholism
Eligibility:
All Genders
18-30 years
Phase:
PHASE1
Brief Summary
This study attempts to characterize the effects of tetrahydrocannabinol (THC). Tetrahydrocannabinol is the active ingredient of marijuana, cannabis, "ganja", or "pot". This study will involve healthy ...
Eligibility Criteria
Inclusion
- Exposure to cannabis at least once
Exclusion
- Pregnancy
Key Trial Info
Start Date :
August 9 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 22 2010
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT00624715
Start Date
August 9 2007
End Date
June 22 2010
Last Update
March 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Connecticut Healthcare System
West Haven, Connecticut, United States, 06516